mono-Methyl glutarate
CAS No. 1501-27-5
mono-Methyl glutarate( METHYL HYDROGEN GLUTARATE )
Catalog No. M19568 CAS No. 1501-27-5
Monomethyl glutaric acid is a metabolite of dibasic esters(DBEs) by nasal respiratory and olfactory mucosae in vitro demonstrated that hydrolysis of DBEs yields mainly the monomethyl esters (monomethyl adipate monomethyl. glutarate and monomethyl succinate).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
1G | 26 | In Stock |
|
Biological Information
-
Product Namemono-Methyl glutarate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMonomethyl glutaric acid is a metabolite of dibasic esters(DBEs) by nasal respiratory and olfactory mucosae in vitro demonstrated that hydrolysis of DBEs yields mainly the monomethyl esters (monomethyl adipate monomethyl. glutarate and monomethyl succinate).
-
DescriptionMonomethyl glutaric acid is a metabolite of dibasic esters(DBEs) by nasal respiratory and olfactory mucosae in vitro demonstrated that hydrolysis of DBEs yields mainly the monomethyl esters (monomethyl adipate monomethyl. glutarate and monomethyl succinate).
-
In Vitro——
-
In Vivo——
-
SynonymsMETHYL HYDROGEN GLUTARATE
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1501-27-5
-
Formula Weight146.14
-
Molecular FormulaC6H10O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCOC(=O)CCCC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hardeman D et al. Abrupt changes in the concentrations of five prostatic tumor-associated markers in serum after acute myocardial infarction. Clin Chem. 1992 Apr;38(4):605-7.
molnova catalog
related products
-
m-PEG12-acid
m-PEG12-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Sulfo-NHS-SS-Biotin ...
Sulfo-NHS-SS-biotin is a cell-impermeant and long-chain cleavable amine-reactive biotinylation reagent.
-
Coptisine
Coptisine treatment increases cell viability based on its reversal effect on the enhanced activity of Indoleamine 2, 3-dioxygenase.